"Talking about the variety that's out there, the lack of regulation, and having things that are independently verified by labs can also enhance the patient outcome," says Bilal Chughtai, MD.
In this video, Bilal Chughtai, MD, shares the key takeaways from the study, “Saw Palmetto Treatment for Prostatitis: A Systematic Review of the Literature,” for which he served as the senior author. Chughtai is the chief of urology at Plainview Hospital at Northwell Health in Plainview, New York.
Video Transcript:
What is the key take-home message from this work?
Supplements have not been part of the armamentarium for urologists. We know that a lot of our patients use these supplements, so I think it's important for us to have a baseline knowledge, at least an idea, of what things we would recommend, what things we don't recommend, and where the data lies. I think having an overall stance of "supplements are all the same, or they're terrible," or whatever it is, I don't think that's a great stance for us. Articles like this really allow us to have an understanding of where it could potentially play a role for our patients.
Is there anything else that you would like to add?
I would just say that the world of supplements is wide and varied. It isn't a well-regulated market. Looking at supplements that have regulation or having the United States Pharmacopeia recommendation on them can definitely be helpful. I think using reputable supplements can also help you go in the right direction. These are all things that we can share with our patients even though we may not have specific supplements that we recommend. Talking about the variety that's out there, the lack of regulation, and having things that are independently verified by labs can also enhance the patient outcome.
This transcription has been edited for clarity.
Study examines patient knowledge of urinary tract infections
July 11th 2024"The objective of this study was to assess baseline knowledge about urinary tract infections, interest in health resources, and platform preferences for health information acquisition and dissemination," says Stephanie Gleicher, MD.
Destigmatizing Urology: Dr. Winter discusses STDs/STIs
March 22nd 2022“We need to just approach STIs as the medical conditions they are because until we do, and until we take those stigmas away, people will truly have resistance to discussing it, hesitance to discussing it, and resistance to diagnosis and intervention,” says Ashley Winter, MD.
Burden of care for recurrent UTI is higher for female urologists
June 15th 2024"What we believe is happening is women are seeking the help of female urologists, and therefore, because of the nature of the condition, the female urologists are absorbing the burden of the care of these patients, particularly the non-billable burden," says Debra L. Fromer, MD.
Predictive model quantifies risk of antibiotic resistance in uUTI
May 24th 2024The predictive models identified the number of previous UTI episodes, prior β-lactam nonsusceptibility, prior fluoroquinolone treatment, Census Bureau region (particularly in the South), and race as key predictors of having a non-susceptible isolate to 3 or more antibiotic classes.